BIO KEY INTERNATIONAL INC (BKYI) Stock Concentration Calculator
Calculator · free · no signup · BKYIQuantify BIO KEY INTERNATIONAL INC concentration risk. Drawdown impact at 30 / 50 / 70%, with the tax-aware trade-off between selling down and hedging.
AlphaLatitude Inc. · Free ToolsOur tools respect your browsing privacy. Independently verified:
Your inputs
Adjust — results update instantly.Position & portfolio
Tax
Most fee-only advisors target ≤10% in any single name. You're at 67%.
Estimates only. Not financial advice.
Most sensitive to: Expected market return (±10% on this input swings best-plan wealth by ±$190,444).
Cost of fully de-concentrating
All three plans sell to 0% (no hedge).Sensitivity. If your expected position return drops below 19.7%/yr, lump-sum (sell everything today) beats every spread plan above.
Have multiple RSU vest lots? The RSU Lot Order Calculator picks which lots to sell first, and on which dates, to divest at the lowest computed tax.
Build your own plan
Toggle below — chart updates live. Sell buttons show the slice.Tech / Software single names hit a 50%+ peak-to-trough drawdown in roughly 1 of every 5 rolling 3-year windows over 2014–2024. Even mega-caps aren’t exempt.
Tax brackets: 2026 · Estimates only — not financial advice.
Estate note. Heirs receive a stepped-up basis at death (§1014), eliminating built-in gain on inherited shares. Older holders who plan to bequeath rather than sell may rationally never de-concentrate.
You sized one position's risk. The beta integrates hedging, sell-down, and tax timing into one optimized plan.
Request beta access →Related calculators: Protect Your Stock Calculator · RSU Lot Order Calculator · Equity Funding Plan Calculator
About BIO KEY INTERNATIONAL INC
BIO KEY INTERNATIONAL INC (BKYI) is a public Cybersecurity company, incorporated in Delaware and headquartered in Holmdel, NJ. IPO'd Feb 21, 1997.
Nasdaq; fingerprint biometric identity/access-management; formerly SAC Technologies (renamed 2002, same continuous operating company); 2026-10-30 S-1 is a follow-on filing by an already-public company, not an IPO prospectus.
Equity grants at BIO KEY INTERNATIONAL INC typically include incentive stock options (ISOs) and non-qualified stock options (NSOs).
BIO-key International traces to 1993, when it began developing fingerprint-based biometric identification technology. Based in Holmdel, New Jersey, the company now sells PortalGuard, an identity and access management (IAM) platform that verifies employee and customer logins using fingerprints, face scans, or multi-factor authentication instead of passwords alone. It trades on Nasdaq under BKYI and reported more than 600 customers as of December 31, 2025, per its 10-K filing. In October 2025, it raised $3.1 million through a warrant inducement priced at $1.02 per share.
Sources: sec.gov · sec.gov · finder.techleap.nl
Equity comp at BIO KEY INTERNATIONAL INC
- BIO-key International is a publicly traded Nasdaq company (BKYI), not a pre-IPO startup. Its 2015 and 2023 stock incentive plans give the Board or Compensation Committee discretion to immediately accelerate vesting of unvested stock options and lift forfeiture restrictions on restricted stock upon a change in control (a single trigger: the deal closing alone can vest awards, no second event like a job loss is required). The CEO's employment agreement adds a separate severance provision if he is not kept on, or is terminated, within five years after a change in control. BIO-key was briefly delisted from Nasdaq in May 2026 for late financial filings, then relisted on July 8, 2026 under ongoing Nasdaq monitoring through mid-2027, and completed a 1-for-10 reverse stock split in 2026.
- Early exercise is not allowed: you have to wait for shares to vest before you can buy them.
Sources: sec.gov · sec.gov · chartmill.com
Researched 2026-11-01.
OptionsAhoy is an independent tool and is not affiliated with, endorsed by, or sponsored by BIO KEY INTERNATIONAL INC.
If a meaningful share of your net worth sits in BKYI, concentration risk is the question. This calculator quantifies drawdown impact at 30 / 50 / 70%, and the trade-off between selling down (tax cost now) versus hedging (option premium drag), auto-filled with BKYI's option-implied volatility.
All BIO KEY INTERNATIONAL INC tools → · Use the generic Stock Concentration Calculator for any company. Diversifying multiple RSU lots? See the lot-by-lot sell order →
BIO KEY INTERNATIONAL INC equity questions
- How much BKYI stock is too much?
- There is no single threshold, but the larger the share of your net worth in one stock, the more a single bad year can set back your plans. The calculator above quantifies the drawdown impact at 30, 50, and 70 percent for your BKYI position and weighs selling down (which triggers capital-gains tax now) against hedging (which costs option premium).
- Does BIO KEY INTERNATIONAL INC grant ISOs, NSOs, or RSUs?
- Equity compensation at BIO KEY INTERNATIONAL INC typically takes the form of incentive stock options (ISOs) and non-qualified stock options (NSOs). Incentive stock options can trigger the alternative minimum tax (AMT) when you exercise.
- Does BIO KEY INTERNATIONAL INC allow early exercise of stock options?
- No. BIO KEY INTERNATIONAL INC requires options to vest before you can exercise them, so the holding-period clock for long-term capital-gains treatment starts as each tranche vests and you exercise it.
Find another companyCybersecurity peers
One piece of the puzzle.
OptionsAhoy plans your BIO KEY INTERNATIONAL INC equity alongside hedging, vesting, and de-concentration, across bullish, neutral, and bearish market scenarios. Free during beta.